Simeprevir plus sofosbuvir for eight or 12 weeks in treatment-naïve and treatment-experienced hepatitis C virus genotype 4 patients with or without cirrhosis.

Saved in:
Bibliographic Details
Title: Simeprevir plus sofosbuvir for eight or 12 weeks in treatment-naïve and treatment-experienced hepatitis C virus genotype 4 patients with or without cirrhosis.
Authors: El Raziky M; Faculty of Medicine, Cairo University, Cairo, Egypt., Gamil M; Janssen Research & Development, Beerse, Belgium., Ashour MK; Faculty of Medicine, Cairo University, Cairo, Egypt., Sameea EA; National Liver Institute, Menoufiya, Egypt., Doss W; National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt., Hamada Y; Faculty of Medicine, Cairo University, Cairo, Egypt., Van Dooren G; Janssen Research & Development, Beerse, Belgium., DeMasi R; Janssen Research & Development, Titusville, NJ, USA., Keim S; Janssen-Cilag Farmacêutica, Barcarena, Portugal., Lonjon-Domanec I; Janssen Pharmaceuticals, Paris, France., Hammad R; National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt., Hashim MS; National Liver Institute, Menoufiya, Egypt., Hassany M; National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt., Waked I; National Liver Institute, Menoufiya, Egypt.
Source: Journal of viral hepatitis [J Viral Hepat] 2017 Feb; Vol. 24 (2), pp. 102-110. Date of Electronic Publication: 2016 Oct 27.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 9435672 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2893 (Electronic) Linking ISSN: 13520504 NLM ISO Abbreviation: J Viral Hepat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2893
DOI:10.1111/jvh.12625